Covid treatments

Monoclonal antibodies therapy is derived from Covid-19 survivors’ own antibodies and designed to fight the infection just as the natural immune system would.

External

 * by Lilly
 * and imdevimab, aka Regen-Cov by Regeneron
 * by Lilly
 * by GSK-Vir Biotechnology

News

 * 20 Aug 2021, (fr) LesEchos.fr, Covid-19 : AstraZeneca tiendrait un traitement préventif potentiellement efficace, Le laboratoire anglo-suédois présente des résultats préliminaires encourageants d'un essai de phase III de son traitement contre le Covid-19 combinant deux anticorps monoclonaux. Il permettrait de réduire fortement le risque de développer des symptômes chez des personnes fragiles. L'occasion de faire un point sur les différents traitements existants.
 * 28 Jul 2021, Pro.politico.eu, European Commission signs contract for coronavirus monoclonal antibody treatment, The signing of the contract with pharma company GlaxoSmithKline for sotrovimab, which GSK developed with Vir Biotechnology, happened Tuesday.
 * 07 Jul 2021, Politico.eu, WHO backs 2 monoclonal antibodies to treat severe covid-19
 * 21 Jun 2021, Reuters.com, Study confirms GSK-Vir antibody drug reduces hospitalization, death in covid-19 patients
 * 15 Jun 2021, Politico.eu, AstraZeneca’s antibody cocktail fails to protect against coronavirus, AZD7442 — a combination of two different monoclonal antibodies — didn’t achieve a statistically significant reduction in the risk of symptomatic covid-19 after exposure to the virus, failing the primary study objective.
 * 04 May 2021, Politico.eu, Cutting-edge coronavirus antibody drugs get their day in Europe, After the US got an early start, a handful of EU countries have rolled out neutralizing antibodies.